HomeNews

News

R-Pharm earned runner-up in BRICS Solutions Awards 2021

R-Pharm`s project on the development of olokizumab has been declared as the Runner-up in the category “Good Health and Well Being” of the BRICS...

Flu Research Institute finishes pre-clinical tests of its COVID-19 vaccine

The Russian health ministry’s Smorodintsev Flu Research Institute has finished pre-clinical tests of its own coronavirus vaccine and plans to begin trials on volunteers...

Vladimir Rusinov: the Virus is Rapidly Mutating

Vladimir Rusinov, the Head of the Laboratory of Organic Synthesis of Ural Federal University, Corresponding Member of RAS, one of the creators of Triazavirin,...

China’s Zhifei says unit’s COVID shot shows 81.76% efficacy in late-stage trial

A COVID-19 vaccine developed by a unit of China's Chongqing Zhifei Biological Products (Zhifei) showed an 81.76% efficacy rate against COVID-19 cases of any degree of severity in a large, late-stage trial, Zhifei said on Friday.

Chumakov Center plans to double CoviVac production in October, says director general

The Chumakov Center plans to double the production of the CoviVac whole-virion vaccine against the coronavirus to 2.5 mln doses per month in October...

Moderna vaccine production continues in EU amid contamination probe

Production of Moderna COVID-19 vaccines at a plant in Spain can continue, the European Union drugs regulator said on Friday, while it carries out its investigation of a suspected metallic contamination incident.
spot_img

Expert Articles

spot_img